We present a woman with a widespread severe papulopustular eruption, fever, and fatigue of 5 weeks' duration. HIV infection was diagnosed, with an absolute CD4 + count of 3 cells/μL. The eruption was consistent with disseminated cutaneous histoplasmosis. The clinical manifestations and management of cutaneous histoplasmosis are reviewed.
CASE DESCRIPTION
A 55-year-old white woman presented to the emergency department reporting a rash of 5 weeks' duration, severe fatigue, and a fever. Initially the rash was present on a localized area of her back, but it rapidly progressed to involve her trunk, face, arms, and legs. She had presented to the emergency department on four separate occasions and was prescribed multiple courses of antibiotics, antihistamines, and corticosteroids without signifi cant improvement. Review of systems was negative for cough, myalgias, arthralgias, and weight loss. A rapid HIV test was positive with an absolute CD4 + count of 3 cells/μL.
On examination, the patient had a widespread papulopustular eruption with lesions coalescing into necrotic plaques with central ulceration over the trunk and extremities. Th ere was secondary impetiginization in places ( Figure 1 ). Punch biopsies were obtained for histopathologic examination and culture ( Figure 2 ).
Histopathology revealed dermal parasitized macrophages with small intracytoplasmic round organisms with surrounding mild chronic infl ammation. Stains demonstrated periodic acid-Schiff (PAS)-positive and Gomori methenamine silver (GMS)-positive yeast within macrophages in the dermis, consistent with histoplasmosis. A Fungitell blood test (1,3 beta-Dglucan) was positive. Computed tomography (CT) of the chest 
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Gabriela M. Soza, BS, Mahir Patel, MD, Allison Readinger, MD, and Caitriona Ryan, MD showed multifocal nodular opacities and mediastinal lymphadenopathy. Th e patient was initiated on intravenous liposomal amphotericin B for histoplasmosis and antiretroviral therapy for HIV. Itraconazole was commenced a few days later for long-term treatment of histoplasmosis. Amphotericin B was discontinued after 3 weeks due to acute kidney injury, and voriconazole was substituted for itraconazole due to concomitant infection with Sporothrix schenckii. Th ere was considerable improvement of the cutaneous lesions, and 1 month after discharge the patient was recommenced on itraconazole for her histoplasmosis. After 3 months of follow-up, the patient had minimal scattered papules and pustules on the face and extremities.
DISCUSSION
Histoplasmosis, the most common endemic mycosis in AIDS patients, is caused by the dimorphic fungus H. capsulatum, a primary pathogen that can cause opportunistic infections in immunocompromised hosts. In the United States, it is prevalent in the Mississippi and Ohio River valleys; worldwide it is endemic in areas of Mexico, Central and South America, Africa, and Asia. Th e fungus is found in soil enriched with bird or bat excreta and is acquired via inhalation of microconidia into the alveoli, where they convert to the yeast form. In immunocompetent hosts, histoplasmosis can present as a self-limiting illness (1) . Patients with advanced AIDS and CD4 lymphocyte counts <100 cells/μL typically present with a more severe, wasting presentation of the disease.
Histoplasmosis has been described in three diff erent forms: acute pulmonary, chronic cavitary, and disseminated histoplasmosis. Of the disseminated cases, 10% to 25% have a wide spectrum of mucocutaneous manifestations (2) . Th ese polymorphous lesions include erythematous macules and papules, plaques, nodules, ulcers, pustules, acneiform eruptions, molluscum-like lesions, and generalized dermatitis. Varying morphologic presentations can occur in a patient, with the face, oropharynx, extremities, and trunk most commonly aff ected (1) . Nonspecifi c fi ndings such as fever and weight loss, cough, and dyspnea are common, with varying degrees of respiratory, hepatic, and reticuloendothelial system involvement (3) .
Th e nonspecifi c skin lesions in disseminated cutaneous histoplasmosis (DCH) can make the diagnosis challenging; thus, a high index of suspicion is necessary. Histopathologic examination of cutaneous lesions is the gold standard diagnostic test, in combination with culture, and is done using special stains including PAS and GMS. Th ese stains highlight numerous intracellular yeast forms 2 to 4 μm in diameter that fi ll a macrophage and appear as basophilic dots with a pseudocapsule (2, 4) . Th ere are a wide variety of histopathologic features, such as necrotizing "tuberculoid" and nonnecrotizing granulomas with small intracellular yeasts, diff use dermal histiocytosis, and diffuse dermal karyorrhexis (2) . Th is appearance of karyorrhexis may mimic leukocytoclastic vasculitis at fi rst glance (4, 5) . Th ese varied fi ndings, in addition to the range of clinical manifestations in DCH, demonstrate a wide spectrum of reaction patterns in this AIDS-defi ning illness (2) .
Histoplasma antigen detection, which can be performed on samples of urine, serum, cerebrospinal fl uid, and bronchoalveolar lavage fl uid, is the most sensitive method of diagnosing disseminated disease (1) . Radiographic imaging should be performed to assess for pulmonary involvement, although initial radiographs may be normal. Common radiographic fi ndings include diff use interstitial or reticulonodular infi ltrates, while pleural eff usions, mediastinal adenopathy, and calcifi ed granulomas can also be observed (3). 
